# Jellagen

生产水母来源的零型胶原蛋白，于2026年初与美国Royal Biologics建立战略合作伙伴关系，将该材料商业化用于北美再生医学市场，涵盖伤口护理及组织工程应用。

Source: https://cn.bioecon.ru/companies/jellagen/
Updated: 2026-07-05

- 国家: United Kingdom

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 员工人数 | 18名员工 | https://bringo.co.uk/company/435496, https://jellagen.co.uk/about/our-company/, https://uk.globaldatabase.com/company/jellagen-limited |
| 认证 | ISO 13485:2016认证 | https://jellagen.co.uk/about/our-company/, https://jellagen.co.uk/collagen-type-0/, https://jellagen.co.uk/files/documents/Whitepapers/Collagen-Type-0-Whitepaper-Web.pdf |
| 生产基地 | 位于威尔士卡迪夫的10,000平方英尺研发及生产设施 | https://jellagen.co.uk/about/our-company/, https://jellagen.co.uk/collagen-type-0/, https://jellagen.co.uk/files/documents/Whitepapers/Collagen-Type-0-Whitepaper-Web.pdf, https://www.mdpi.com/2310-2861/9/3/247 |
| 产能 | 有潜力以任何水母物种为原料实现大规模生产 [中等置信度] | https://jellagen.co.uk/files/documents/Whitepapers/Collagen-Type-0-Whitepaper-Web.pdf |
| 监管批准 | 目前处于产品开发阶段,朝向人体试验和监管申报推进 [中等置信度] | https://jellagen.co.uk/about/jellagen-news/news/jellagen-closes-8.7m-series-a-funding-round-to-accelerate-development-of-collagen-type-0-and-revolutionise-regenerative-medicine |

独立来源: bringo.co.uk, mdpi.com, uk.globaldatabase.com

## 技术

- [重组胶原蛋白与明胶](https://cn.bioecon.ru/technology/recombinant-collagen-gelatin/)